glp 1 and digestive issues Starting a GLP-1 medication can be a game-changer for your health, but the side effects can be a major challenge. Whether you're dealing with muscle loss, fatigue or issues, small changes Secretion of GLP-1 from the

The evidence for GLP-1 medications in treating NASH (the more severe form of fatty liver disease) is particularly impressive: Liraglutide achieved histological resolution of steatohepatitis in 39% of cases after 48 weeks, compared to just 9% in placebo groups 20 Patients taking liraglutide had 4.5 times higher likelihood of NASH resolution than those on placebo 20 Semaglutide demonstrated NASH resolution in 59% of participants versus 17% in placebo groups 21 We offer FibroScan technology to measure liver stiffness and fat content, helping us monitor your progress while on GLP-1 therapy

doi: 10.2147/NDT.S333154 12

Jumper, J

Sattar N, Petrie MC, Zinman B, Januzzi JL Jr